resveratrol has been researched along with Prostatic Intraepithelial Neoplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Ghosh, R; Hu, M; Huang, SB; Kumar, AP; Lai, Z; Reddick, RL; Rivas, P; Schadler, KL; Yang, X | 1 |
Bedolla, R; Ghosh, R; Kumar, AP; Li, G; Reddick, RL; Rivas, P; Thapa, D | 1 |
2 other study(ies) available for resveratrol and Prostatic Intraepithelial Neoplasia
Article | Year |
---|---|
SIRT1 inhibition-induced senescence as a strategy to prevent prostate cancer progression.
Topics: Androgen Antagonists; Animals; Cellular Senescence; Humans; Male; Mice; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Resveratrol; Sirtuin 1 | 2022 |
Dietary resveratrol prevents development of high-grade prostatic intraepithelial neoplastic lesions: involvement of SIRT1/S6K axis.
Topics: Animal Feed; Animals; Cell Line, Tumor; Cell Survival; Diet; Humans; Immunohistochemistry; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Multiprotein Complexes; Mutation; Phosphorylation; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Resveratrol; Ribosomal Protein S6 Kinases; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Stilbenes; Tetrazolium Salts; Thiazoles; Time Factors; TOR Serine-Threonine Kinases | 2013 |